(Ala13)-Apelin-13
(Ala13)-Apelin-13 is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 inhibits gastric motility through vagal cholinergic pathway.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 568565-11-7
- Fòrmula: C63H107N23O16S
- Peso molecular:1474.73
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:250-300 g, Sprague-Dawley rats[1]
-
Dosage:1-300 pmol/60 nl
-
Administration:Microinjected into the DVC (dorsal vagal complex (DVC)
-
Result:Decreased gastric tone and motility in a dose-dependent manner with D50 ≈ 27 pmol for both antrum and corpus.
Chemical Information
-
No. CAS 568565-11-7
-
Peso molecular 1474.73
-
Fòrmula C63H107N23O16S
-
Sequence
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala
-
Sequence Shortening
QRPRLSHKGPMPA
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Bülbül M, et al. Apelin-13 inhibits gastric motility through vagal cholinergic pathway in rats. Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G201-G210. [Content Brief]
[2]. O'Harte FPM,et al. Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties. Biochem Pharmacol. 2017 Dec 15;146:165-173. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)